Nyx Bioscience

NYX Bioscience uses proprietary synthetic biology methods to produce natural biopolymers at an industrial scale by cloning specific genes into photosynthetic organisms. The company leverages expertise in algae biofuels, microbial cultivation, and gene editing to control product purity while reducing manufacturing costs. Their approach aims to disrupt existing markets by providing a cost-effective, scalable alternative to traditional biopolymer production methods.

This technology is designed to address the need for sustainable and high-value natural biomolecules across various industries. By focusing on lab-scale optimization, including gene editing and yield improvements, the company intends to transition from pilot-scale performance validation to broader commercial applications. Their leadership team brings significant experience from organizations such as Monsanto, Indigo Ag, and Joule to guide the development, regulatory compliance, and commercialization of their biotech solutions.